SYMBICORT TURBUHALER 1604.5 mcgdose Singapúr - enska - HSA (Health Sciences Authority)

symbicort turbuhaler 1604.5 mcgdose

astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 160 mcg/dose - budesonide 160 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose

SYMBICORT TURBUHALER 804.5 mcgdose Singapúr - enska - HSA (Health Sciences Authority)

symbicort turbuhaler 804.5 mcgdose

astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 80 mcg/dose - budesonide 80 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose

Foster Pressurised Inhalation Solution 100mcg6mcg per Actuation Singapúr - enska - HSA (Health Sciences Authority)

foster pressurised inhalation solution 100mcg6mcg per actuation

orient europharma pte ltd - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - aerosol, metered - 0.100mg/ actuation - beclometasone dipropionate anhydrous 0.100mg/ actuation; formoterol fumarate dihydrate 0.006mg/actuation

FLUTIFORM® PRESSURISED INHALATION SUSPENSION 125 MICROGRAM5 MICROGRAM PER ACTUATION Singapúr - enska - HSA (Health Sciences Authority)

flutiform® pressurised inhalation suspension 125 microgram5 microgram per actuation

mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 125 mcg/actuation - fluticasone propionate 125 mcg/actuation; formoterol fumarate dihydrate 5 mcg/actuation

FLUTIFORM® PRESSURISED INHALATION SUSPENSION 250 MICROGRAM10 MICROGRAM PER ACTUATION Singapúr - enska - HSA (Health Sciences Authority)

flutiform® pressurised inhalation suspension 250 microgram10 microgram per actuation

mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 250 mcg/actuation - fluticasone propionate 250 mcg/actuation; formoterol fumarate dihydrate 10 mcg/actuation

Cofsed Linctus Malta - enska - Medicines Authority

cofsed linctus

thornton & ross limited linthwaite laboratories, huddersfield, hd7 5qh, united kingdom - chlorphenamine maleate, pholcodine, ephedrine hydrochloride - oral suspension - chlorphenamine maleate 2 mg/5ml pholcodine 5 mg/5ml ephedrine hydrochloride 8 mg/5ml - cough and cold preparations

MEDISIP WITH DECONGESTANT POWDER FOR ORAL SOLUTION 500/12.2 Milligram Powder for Oral Solution Írland - enska - HPRA (Health Products Regulatory Authority)

medisip with decongestant powder for oral solution 500/12.2 milligram powder for oral solution

actavis group ptc ehf - paracetamol, phenylephrine hydrochloride - powder for oral solution - 500/12.2 milligram - analgesics and antipyretics

Rowasip Cold and Flu with Decongestant 500 mg/12.2 mg powder for oral solution Írland - enska - HPRA (Health Products Regulatory Authority)

rowasip cold and flu with decongestant 500 mg/12.2 mg powder for oral solution

rowex ltd - paracetamol; phenylephrine hydrochloride - powder for oral solution - 500 mg/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

Rowasip Max Strength Cold and Flu with Decongestant 1000 mg/12.2 mg powder for oral solution Írland - enska - HPRA (Health Products Regulatory Authority)

rowasip max strength cold and flu with decongestant 1000 mg/12.2 mg powder for oral solution

rowex ltd - phenylephrine hydrochloride; paracetamol - powder for oral solution - 1000 mg/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics

BiResp Spiromax Evrópusambandið - enska - EMA (European Medicines Agency)

biresp spiromax

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drugs for obstructive airway diseases, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists.orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists.copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁)